Structures by: Fathima N.
Total: 11
2-(3,4-Difluorophenyl)-1<i>H</i>-benzimidazole
C13H8F2N2
Acta Crystallographica Section E (2013) 69, 11 o1689
a=8.7195(17)Å b=9.9454(19)Å c=23.389(4)Å
α=90.00° β=90.00° γ=90.00°
6-Chloro-3-[(dimethylamino)methylidene]thiochroman-4-one
C12H12ClNOS
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 10 o1521
a=11.0031(3)Å b=12.5937(3)Å c=13.0787(3)Å
α=90.00° β=100.255(2)° γ=90.00°
Methyl 5-(4-acetoxyphenyl)-2-(2-bromobenzylidine)-7-methyl-3-oxo-2,3-dihydro-5<i>H</i>-1,3-thiazolo[3,2-<i>a</i>]pyrimidine-6-carboxylate
C24H19BrN2O5S
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 8 o1262
a=7.6018(5)Å b=11.9648(7)Å c=14.0877(9)Å
α=106.4250(10)° β=104.700(2)° γ=106.2960(10)°
2-[4-(Trifluoromethoxy)phenyl]-1<i>H</i>-benzimidazole
C14H9F3N2O
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 2 o264
a=14.476(6)Å b=9.312(4)Å c=9.835(4)Å
α=90.00° β=108.192(8)° γ=90.00°
Methyl 4-(4-hydroxyphenyl)-6-methyl-2-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carboxylate
C13H14N2O3S
Acta crystallographica. Section E, Structure reports online (2014) 70, Pt 3 o306
a=7.3016(12)Å b=7.6855(13)Å c=11.4706(19)Å
α=88.337(3)° β=84.870(3)° γ=89.937(3)°
2-Phenyl-8,9,10,11-tetrahydro-1- benzothieno[3,2-<i>e</i>][1,2,4]triazolo[1,5-<i>c</i>]pyrimidine
C17H14N4S
Acta Crystallographica Section E (2011) 67, 4 o777-o778
a=8.6239(16)Å b=20.512(4)Å c=8.5952(16)Å
α=90.00° β=111.975(3)° γ=90.00°
2-Amino-4-methyl-4,5,6,7-tetrahydro-1-benzothiophene-3-carbonitrile
C10H12N2S
Acta Crystallographica Section E (2012) 68, 10 o3025
a=9.6771(2)Å b=7.6364(2)Å c=13.8156(3)Å
α=90.00° β=100.221(2)° γ=90.00°
1-(2-Chloroethyl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4(5<i>H</i>)-one
C7H7ClN4O
Acta Crystallographica Section E (2012) 68, 7 o2083
a=4.64480(10)Å b=8.07920(10)Å c=22.7335(4)Å
α=90.00° β=93.5540(10)° γ=90.00°
Methyl 2-(2-bromobenzylidene)-5-(4-hydroxyphenyl)-7-methyl-3-oxo-2,3-dihydro- 5<i>H</i>-1,3-thiazolo[3,2-<i>a</i>]pyrimidine-6-carboxylate
C22H17BrN2O4S
Acta Crystallographica Section E (2012) 68, 4 o1257-o1258
a=9.851(2)Å b=23.461(6)Å c=9.416(2)Å
α=90.00° β=111.229(5)° γ=90.00°
Ethyl 3-acetyl-4-(3-methoxyphenyl)-6-methyl-2-sulfanylidene-1,2,3,4- tetrahydropyrimidine-5-carboxylate
C17H20N2O4S
Acta Crystallographica Section E (2012) 68, 5 o1555
a=11.515(2)Å b=7.3687(16)Å c=20.049(4)Å
α=90.00° β=90.960(4)° γ=90.00°
4-Imino-2,7-dimethyl-5,6,7,8-tetrahydro-4<i>H</i>- 1-benzothieno[2,3-<i>d</i>]pyrimidin-3-amine
C12H16N4S
Acta Crystallographica Section E (2012) 68, 8 o2468
a=6.7514(5)Å b=8.7139(6)Å c=11.8309(9)Å
α=97.221(4)° β=102.820(4)° γ=112.482(3)°